As of 2025-09-17, the Relative Valuation of Passage Bio Inc (PASG) is (248.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.27 USD, the upside of Passage Bio Inc based on Relative Valuation is -3518.4%.
The range of the Relative Valuation is (247.09) - (307.88) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.8x - 17.2x | 13.9x |
| Forward P/E multiples | 13.8x - 20.2x | 13.9x |
| Fair Price | (247.09) - (307.88) | (248.52) |
| Upside | -3498.7% - -4334.9% | -3518.4% |
| Date | P/E |
| 2025-09-11 | -0.39 |
| 2025-09-10 | -0.39 |
| 2025-09-09 | -0.39 |
| 2025-09-08 | -0.39 |
| 2025-09-05 | -0.40 |
| 2025-09-04 | -0.39 |
| 2025-09-03 | -0.40 |
| 2025-09-02 | -0.40 |
| 2025-08-29 | -0.40 |
| 2025-08-28 | -0.39 |
| 2025-08-27 | -0.39 |
| 2025-08-26 | -0.39 |
| 2025-08-25 | -0.42 |
| 2025-08-22 | -0.42 |
| 2025-08-21 | -0.41 |
| 2025-08-20 | -0.43 |
| 2025-08-19 | -0.39 |
| 2025-08-18 | -0.40 |
| 2025-08-15 | -0.39 |
| 2025-08-14 | -0.42 |
| 2025-08-13 | -0.36 |
| 2025-08-12 | -0.31 |
| 2025-08-11 | -0.33 |
| 2025-08-08 | -0.35 |
| 2025-08-07 | -0.31 |
| 2025-08-06 | -0.32 |
| 2025-08-05 | -0.32 |
| 2025-08-04 | -0.32 |
| 2025-08-01 | -0.32 |
| 2025-07-31 | -0.36 |
| 2025-07-30 | -0.34 |
| 2025-07-29 | -0.35 |
| 2025-07-28 | -0.39 |
| 2025-07-25 | -0.42 |
| 2025-07-24 | -0.32 |
| 2025-07-23 | -0.32 |
| 2025-07-22 | -0.32 |
| 2025-07-21 | -0.29 |
| 2025-07-18 | -0.31 |
| 2025-07-17 | -0.32 |
| 2025-07-16 | -0.31 |
| 2025-07-15 | -0.33 |
| 2025-07-14 | -0.38 |
| 2025-07-11 | -0.45 |
| 2025-07-10 | -0.44 |
| 2025-07-09 | -0.49 |
| 2025-07-08 | -0.45 |
| 2025-07-07 | -0.48 |
| 2025-07-03 | -0.52 |
| 2025-07-02 | -0.45 |